KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Debt Ratio (2020 - 2025)

Regeneron Pharmaceuticals (REGN) has 5 years of Debt Ratio data on record, last reported at 0.05 in Q3 2025.

  • For Q3 2025, Debt Ratio fell 6.72% year-over-year to 0.05; the TTM value through Sep 2025 reached 0.05, down 6.72%, while the annual FY2024 figure was 0.05, 12.33% down from the prior year.
  • Debt Ratio reached 0.05 in Q3 2025 per REGN's latest filing, down from 0.05 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.07 in Q2 2022 and bottomed at 0.05 in Q3 2025.
  • Average Debt Ratio over 4 years is 0.06, with a median of 0.06 recorded in 2023.
  • Peak YoY movement for Debt Ratio: fell 14.04% in 2024, then decreased 6.72% in 2025.
  • A 4-year view of Debt Ratio shows it stood at 0.07 in 2022, then decreased by 11.62% to 0.06 in 2023, then dropped by 12.33% to 0.05 in 2024, then dropped by 5.95% to 0.05 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.05 in Q3 2025, 0.05 in Q2 2025, and 0.05 in Q1 2025.